IMBED’S MICROLYTE MATRIX ADDED TO VA’S IDIQ CONTRACT
Embargo FOR RELEASE on Tuesday, Feb 15th, 2022 IMBED’S MICROLYTE MATRIX ADDED TO VA’S IDIQ CONTRACT February 15, 2022 (Madison, WI) – Imbed Biosciences Inc. (Imbed), a developer of next-generation therapies for tissue repair, and Spartan Medical, a veteran-owned Federal Contractor with fourteen years of… Read More »IMBED’S MICROLYTE MATRIX ADDED TO VA’S IDIQ CONTRACT